Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Minerva Neurosciences, Inc. (NERV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.0400+0.0500 (+1.67%)
At close: 04:00PM EST
2.8500 -0.19 (-6.25%)
After hours: 05:16PM EST
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Minerva Neurosciences Reports Third Quarter 2022 Financial Results and Business Updates

    Company To Host Live Webcast Today at 8:30 a.m. ETBURLINGTON, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported key business updates and financial results for the quarter ended September 30, 2022. Roluperidone Update As announced on August 17, 2022, the company submitted to the U.S. Food and Drug Administration (FDA)

  • GlobeNewswire

    Minerva Neurosciences to Report Third Quarter 2022 Financial Results and Business Updates on November 9, 2022

    BURLINGTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the third quarter of 2022 on Wednesday, November 9, 2022. The Company will host a webcast that day at 8:30 a.m. Eastern Time to discuss the results and updates. The live conference call may b

  • Zacks

    Biotech Stock Roundup: NERV, RLMD Down on Updates, MRNA, NVAX's News & More

    Regulatory and pipeline updates from NERV and RLMD are the key highlights from the biotech sector during the past week.

Advertisement
Advertisement